Equity · Healthcare
ARDX
NASDAQArdelyx (ARDX)
The line runs 3.97 USD on 12 August through 2.94 USD on 9 November, on a scale from 2.5 to 4.5. Days the market did not trade hold the previous close, flat.
- Market cap
- 737.8M USD
- Revenue, year to Dec 2025
- 407.3M USD
- EPS, diluted, year to Dec 2025
- −0.26 USD
- 52-week range
- 2.86 USD – 8 USD
- Avg volume
- 442.6K
as of Nov 9, 2026
Have Ardelyx (ARDX) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, Ardelyx insiders reported 8 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 20 Feb 2026.
Form 4, 90 days to 10 Nov 2026, newest reported trade 21 Aug 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 21 Aug 2026 | Bishop John ESee Remarks | Sell | 19,750 | 76K USD |
| 21 Aug 2026 | RAAB MICHAELPresident & CEO | Sell | 58,574 | 226K USD |
| 21 Aug 2026 | Williams Laura AChief Patient Officer | Sell | 10,739 | 41K USD |
| 21 Aug 2026 | Kelliher MikeChief Business Officer | Sell | 7,758 | 30K USD |
| 21 Aug 2026 | Foster Eric DuaneChief Commercial Officer | Sell | 8,562 | 33K USD |
| 21 Aug 2026 | Reilly Joseph JamesSee Remarks | Sell | 3,982 | 15K USD |
| 21 Aug 2026 | Brady James ParkerChief Human Resources Officer | Sell | 15,136 | 58K USD |
| 21 Aug 2026 | Hohenleitner SusanChief Financial Officer | Sell | 1,558 | 6K USD |
| Sold | 8 open-market sales | 126,059 | $486K |
Which funds hold Ardelyx (ARDX)?
8 of the 45 institutional funds we track reported a Ardelyx position for the quarter ended 30 Jun 2026 — a combined 119.8M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Millennium Management | Held (±25%) | 13,900,773 | 70.9M USD | −22.1% |
| Two Sigma Investments | Held (±25%) | 5,209,823 | 26.6M USD | +21.9% |
| AQR Capital Management | Held (±25%) | 2,316,220 | 11.8M USD | −5.1% |
| Citadel Advisors | Trimmed | 1,030,174 | 5.3M USD | −70.3% |
| Renaissance Technologies | Trimmed | 892,593 | 4.6M USD | −29.9% |
| Balyasny Asset Management | Trimmed | 76,598 | 391K USD | −61.7% |
| Marshall Wace | Trimmed | 56,495 | 288K USD | −96.5% |
| D. E. Shaw & Co. | Trimmed | 13,081 | 67K USD | −95.8% |
| Man Group | Exited | |||
| Point72 Asset Management | Exited |
What has been filed or recorded for Ardelyx (ARDX)?
The filings we hold for Ardelyx, newest first: 1 fails-to-deliver day, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 09 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 54 shares | 177 USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.00 USD | |
| 30 Sep 2026 | Financials | Total assets | 587.5M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 164.0M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.07 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.15 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −0.26 USD | |
| 31 Dec 2025 | Financials | Revenue | 407.3M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −61.6M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −0.26 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.00 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.08 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.17 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −0.17 USD |
What do people ask about Ardelyx (ARDX)?
What did Ardelyx shares close at?2.94
Ardelyx closed at 2.94 USD on 9 Nov 2026, up 2.62% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Ardelyx’s market cap?737.8M
Ardelyx is worth 737.8M USD by market value as of 9 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Ardelyx’s revenue?407.3M
Ardelyx reported revenue of 407.3M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Ardelyx insiders bought or sold shares recently?8 sales
In the 90 days to 10 Nov 2026, Ardelyx insiders reported 8 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 20 Feb 2026. See Insiders
Which funds own Ardelyx?8 of 45
8 of the 45 funds we track reported a Ardelyx position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, Two Sigma Investments and AQR Capital Management. See Funds
When did Ardelyx last report earnings?0.00
Ardelyx last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.00 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings